Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?

Author(s):  
Yubin Lee ◽  
Tae Hyung Kim ◽  
Jae Kyun Park ◽  
Jin Hee Eum ◽  
Hee Jun Lee ◽  
...  
F1000Research ◽  
2019 ◽  
Vol 8 ◽  
pp. 1585
Author(s):  
Bruna Estácio da Veiga ◽  
Duarte Pedro Tavares ◽  
José Luis Metello ◽  
Fernando Ferreira ◽  
Pedro Ferreira ◽  
...  

Background: In developed countries, the prevalence of infertility ranges from 3.5% to 16.7%. Therefore, the number of in vitro fertilization technique (IVF) and its subtype intracytoplasmic sperm injection (ICSI) treatments has been significantly increasing across Europe. Several factors affect the success rate of in vitro treatments, which can be used to calculate the probability of success for each couple. As these treatments are complicated and expensive with a variable probability of success, the most common question asked by IVF patients is ‘‘What are my chances of conceiving?”. The main aim of this study is to develop a validated model that estimates the chance of a live birth before they start their IVF non-donor cycle. Methods: A logistic regression model was developed based on the retrospective study of 737 IVF cycles. Each couple was characterized by 14 variables (woman’s and man’s age, duration of infertility, cause of infertility, woman’s and man’s body mass index (BMI), anti-Müllerian hormone (AMH), antral follicle count (AFC), woman’s and man’s ethnicity, woman’s and man’s smoking status and woman’s and man’s previous live children) and described with the outcome of the treatment "Live birth" or "No live birth". Results: The model results showed that from the 14 variables acquired before starting the IVF procedures, only male factor, man’s BMI, man's mixed ethnicity and level of AMH were statistically significant. The interactions between infertility duration and woman’s age, infertility duration and man’s BMI, AFC and AMH, AFC and woman’s age, AFC and woman’s BMI and AFC and disovulation were also statistically significant. The area under the receiver operating characteristic (AUROC) curve test for the discriminatory ability of the final prediction model is 0.700 (95% confidence interval (CI) 0.660–0.741). Conclusions: This model might result in a new validated decision support system to help physicians to manage couples’ expectations.


BMJ Open ◽  
2017 ◽  
Vol 7 (10) ◽  
pp. e018107 ◽  
Author(s):  
Kevin N Keane ◽  
John L Yovich ◽  
Anahita Hamidi ◽  
Peter M Hinchliffe ◽  
Satvinder S Dhaliwal

BackgroundPatients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies in order to enhance success rates, but the true benefit is actively debated. Growth hormone (GH) supplementation was assessed in poor-prognosis women undergoing fresh IVF transfer cycles.MethodsData were retrospectively analysed from 400 IVF cycles, where 161 women received GH and 239 did not.ResultsClinical pregnancy, live birth rates and corresponding ORs and CIs were significantly greater with GH, despite patients being significantly older with lower ovarian reserve. Patient’s age, quality of transferred embryo and GH were the only significant independent predictors of clinical pregnancy (OR: 0.90, 5.00 and 2.49, p<0.002, respectively) and live birth chance (OR: 0.91, 3.90 and 4.75, p<0.014, respectively). GH increased clinical pregnancy chance by 3.42-fold (95% CI 1.82 to 6.44, p<0.0005) and live birth chance by 6.16-fold (95% CI 2.83 to 13.39, p<0.0005) after adjustment for maternal age, antral follicle count and transferred embryo quality.ConclusionThese data provided further evidence to indicate that GH may support more live births, particularly in younger women. It also appears that embryos generated under GH have a better implantation potential, but whether the biological mechanism is embryo-mediated or endometrium-mediated is unclear.


2011 ◽  
Vol 96 (6) ◽  
pp. 1514-1518 ◽  
Author(s):  
Luk Rombauts ◽  
Joseph L. Onwude ◽  
Hong W. Chew ◽  
Beverley J. Vollenhoven

IVF Lite ◽  
2016 ◽  
Vol 3 (3) ◽  
pp. 104
Author(s):  
StevenR Lindheim ◽  
Samantha Simpson ◽  
IlanaB Ressler ◽  
Peter Kovacs ◽  
Rachel Warwar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document